Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Escitalopram
Drug ID BADD_D00809
Description Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]
Indications and Usage Labeled indications include major depressive disorder (MDD) and generalized anxiety disorder (GAD). Unlabeled indications include treatment of mild dementia-associated agitation in nonpsychotic patients.
Marketing Status Prescription
ATC Code N06AB10
DrugBank ID DB01175
KEGG ID D07913
MeSH ID D000089983
PubChem ID 146570
TTD Drug ID D08RBC
NDC Product Code 68071-2051; 68071-2035; 51655-284; 68071-4984; 68071-5248; 70518-2472; 65162-705; 42708-023; 70518-1110; 0456-2010; 63187-281; 71610-425; 61919-652; 63187-217; 50090-3331; 16729-168; 55700-847; 69097-849; 45865-699; 76282-249; 71335-1002; 0456-2005; 43547-281; 67296-1421; 0615-8349; 68001-455; 70518-2597; 63629-8241; 70518-3151; 68071-4985; 67296-1200; 33342-053; 51655-449; 53002-1438; 70934-112; 70771-1146; 68788-7510; 68788-7559; 16729-170; 0615-8348; 70518-1876; 70518-2317; 43063-661; 70518-2430; 71335-1307; 43547-282; 50090-4915; 70771-1147; 55700-818; 0615-8366; 68001-456; 71335-1571; 16729-169; 69097-848; 71335-1187; 70518-1805; 70518-1785; 67296-1689; 68645-520; 60760-393; 53002-2438; 50090-4363; 76282-251; 71205-344; 71335-1241; 50090-1930; 60760-170; 0615-8365; 68788-7461; 42708-022; 72789-194; 54838-551; 76282-250; 68788-7912; 0456-2020; 69097-847; 68001-454; 68645-519; 50090-5312; 67296-1597; 71205-325; 53002-1453; 43547-280; 71335-1030; 0615-8350; 68071-3069; 50090-2196; 67296-1408; 71610-534; 70771-1145; 71335-2058
Synonyms Escitalopram | Escitalopram Oxalate | Lexapro
Chemical Information
Molecular Formula C20H21FN2O
CAS Registry Number 128196-01-0
SMILES CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.0020.001900%
Abdominal pain upper07.01.05.0030.001092%
Abnormal dreams19.02.03.001; 17.15.02.0010.000522%Not Available
Abortion spontaneous18.01.04.001--Not Available
Abscess11.01.08.001--Not Available
Acanthosis nigricans23.01.04.001; 16.32.01.0030.000095%Not Available
Accommodation disorder06.02.04.001--Not Available
Acne23.02.01.001--Not Available
Acute psychosis19.03.01.001--Not Available
Acute respiratory distress syndrome22.01.03.0010.000190%
Acute sinusitis22.07.03.013; 11.01.13.012--Not Available
Affective disorder19.04.04.0010.000237%Not Available
Aggression19.05.01.0010.001805%Not Available
Agitation19.06.02.001; 17.02.05.0120.002945%
Agitation neonatal19.06.02.007; 18.04.04.002; 17.02.05.0280.000095%Not Available
Agranulocytosis01.02.03.001--Not Available
Akathisia19.06.02.006; 17.01.02.0020.000617%
Alanine aminotransferase increased13.03.01.003--
Alcohol abuse19.07.02.0070.000522%Not Available
Alcohol problem19.07.02.013--Not Available
Alcoholism19.07.02.0010.000760%Not Available
Alopecia23.02.02.001--
Altered state of consciousness19.07.01.003; 17.02.04.0010.000332%Not Available
Amblyopia06.02.01.001--Not Available
Amenorrhoea21.01.02.001; 05.05.01.0020.000475%
Amnesia19.20.01.001; 17.03.02.0010.000522%
Anaemia01.03.02.001--
Anal atresia07.13.05.001; 03.04.06.0010.000142%Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 38 Pages